GB Patent

GB201208238D0 — Foam control formulations

Assigned to Rhodia Operations SAS · Expires 2012-06-20 · 14y expired

What this patent protects

The invention provides a foam control formulation in the form of a microemulsion, the formulation comprising: (a) from 5 to 70% w/w of primary surfactant, this surfactant having an HLB of from 1 to 12 and/or a cloud point of from 20 to 70°C; (b) from 2 to 40% w/w of water-insolub…

USPTO Abstract

The invention provides a foam control formulation in the form of a microemulsion, the formulation comprising: (a) from 5 to 70% w/w of primary surfactant, this surfactant having an HLB of from 1 to 12 and/or a cloud point of from 20 to 70°C; (b) from 2 to 40% w/w of water-insoluble organic carrier liquid; and (c) water. Also provided is the use of this formulation to prevent and/or reduce foam in a fluid system, or as a processing aid to control foam production in a fluid system. The formulation may be used in an aqueous fluid system, such as an oilfield.

Drugs covered by this patent

Patent Metadata

Patent number
GB201208238D0
Jurisdiction
GB
Classification
Expires
2012-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Rhodia Operations SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.